Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Goldman Sachs Initiates Coverage On HP with Neutral Rating

Goldman Sachs analyst Michael Ng initiates coverage on HP (NYSE:HPQ) with a Neutral rating.
byBenzinga Newsdesk
March 20, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Goldman Sachs analyst Michael Ng initiates coverage on HP (NYSE:HPQ) with a Neutral rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Mydecine’s Prospectus Supplement Closing Under Share Subscription And Management Update

By Lara Goldstein
May 30, 8:30 PM
Colorado-based next-generation psychedelics biotech Mydecine Innovations Group Inc. (OTC: MYCOF) announced that, in connection with its common share subscription agreement with a third-party investor dated this past March 10, it has filed a shelf prospectus supplement to its final base shelf prospectus for th

MYCOF

Read More

After Initial Rejection, FDA Approves Ardelyx’s Kidney Disease-Related Drug

By Vandana Singh
October 18, 8:29 AM
The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have inadequate response to phosphate binders or

ARDX